Navigation Links
NxStage Medical Reports First Quarter 2008 Results
Date:5/12/2008

55 dialysis centers to provide home hemodialysis therapy to 2,481 end-stage renal disease (ESRD) patients prescribed to receive therapy with the Company's System One(TM) portable dialysis machine. This compares to 200 centers and 1,295 patients at the end of the first quarter of 2007 and 334 centers and 2,223 patients at the end of the fourth quarter of 2007.

"The scale and breadth of our three markets combined to drive revenue growth and gross margin improvement in the quarter. We are confident that home daily hemodialysis is a significant market opportunity in particular, over the long-term because of its clear patient benefits. We remain focused on delivering on our top line growth and economic improvement initiatives," said Jeffrey H. Burbank, President & CEO of NxStage Medical.

Recent Highlights

-- In May 2008, the Company estimates that more than one million home

treatments have been performed with the System One.

-- In May 2008, Medisystems Corporation, the Company's wholly-owned

subsidiary, entered into a new supply and distribution agreement with

Kawasumi Laboratories, Inc. regarding Kawasumi's continued supply of

blood tubing sets to Medisystems through January 31, 2010.

-- In March 2008, Tom Shea joined the Company as Senior Vice President of

Manufacturing Operations. Mr. Shea is responsible for all of NxStage's

manufacturing operations, including the Company's five manufacturing

facilities.

-- In February 2008, the Company began patient enrollment in an FDA IDE

study in support of a nocturnal indication for the System One.

-- In February 2008, Emil Paganini, MD, formerly Section Head of Dialysis

and Extracorporeal Therapy with the Cleveland Clinic Foundation,

joined the Company as Critical Care Medical Advisor. Dr. Paganini

provides physician leadership for corporate clinical, scientifi
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. NxStage Medical Completes Acquisition of Medisystems
2. NxStage Medical Reports Third Quarter 2007 Results
3. NxStage Medical Establishes $50 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital
4. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
5. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
6. NxStage Medical Reports Fourth Quarter and Full Year 2007 Results
7. Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
8. Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc.
9. NxStage Announces Supply Agreement With Kawasumi Laboratories for Blood Tubing Sets
10. MSU engineering team designs innovative medical device
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...rding the treatment of AIDS/HIV infection that has...f a global research, AIDS still remains a puzzle t...nt of patients with HIV, or human immunodeficiency...very slowly.// Past research suggested that such ...
...s who make fewer visits to the dentists than their... the fact that smoking puts them more at risk from...holds true regardless of age, gender, race, ethnic..., location and insurance coverage. The study, repo...
...sity College of Medicine and Public Health had fou...esponding well to other treatments might be treate...NS) with significantly better results.// As an al...pproved the implantation of a vagus nerve stimulat...
...ch the oxygen-carrying protein in the red blood ce...ickled) shape that can disrupt circulation, leadin...es fatal complications. // "Sickle cell anemia is...disables children as they grow," according to Dr.W...
Other Medicine News:Health News:Study holds promise for new way to fight HIV 2Health News:Children With Epilepsy Can Be Treated With Nerve Stimulation 2Health News:Initiation Of New Study To Help Children With Sickle Cell Anaemia 2
(Date:7/22/2008)...alidated by Columbia University Medical Center Bas...oRNA Technology, The Test Differentiates Squamou...SCLC), Classifying Squamous-Cell Carcinoma of the ...cificity of 90 Percent,This is the First CLIA Appr... as Biomarkers for Accurate Diagnosis of Lu...
(Date:7/22/2008)...ests That Ekkyo,s New Approach of LASH (Laser Assi...r Healing Physiology, MARSEILLES, France, July 22... Technology) a photomedicine company, which develo...r prevention and reduction, announced today,the pu...gery and Medicine*,reporting the results of a pilo...
(Date:7/21/2008).../- The SEAS (Simvastatin and Ezetimib...ffects of intensive,cholesterol lowering with the ...mibe (10 mg daily) in patients with aortic stenosi...age of the aortic valve in,the heart) is a relativ...opulations. Left untreated, it can progress to dea...
(Date:7/21/2008)...profile helps clinicians identify risk in patients...evels and statin therapy, BIRMINGHAM, Ala., July ...from Atherotech, researchers have identified a lin...n. The information could help,physicians trying to...,disease risk-lowering treatments in at-risk patie...
Breaking Medicine Technology:First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3Natural Solutions May Issue Illustrates Cocktail Effect of Everyday Toxins 3B Offers Tips to Reduce Toxic Load 18746 1Natural Solutions May Issue Illustrates Cocktail Effect of Everyday Toxins 3B Offers Tips to Reduce Toxic Load 18746 2Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 1Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 2Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 3Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 4Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 1Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 2Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 3Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 4Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 5Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 6Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 7Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 8Anacor to Present Clinical and Preclinical Data on Topical Anti Inflammatory Candidates AN2728 and AN2898 at the International Investigative Dermato 5208 1Anacor to Present Clinical and Preclinical Data on Topical Anti Inflammatory Candidates AN2728 and AN2898 at the International Investigative Dermato 5208 2